Rallybio Stock Quote RLYB - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

1.61

Bid

1.60

Ask

1.71

Volume

324,917

1.54 Day's Range 1.72

1.225 52 Week Range 9.14

Market Cap

62.768M

Previous Close

1.58

Open

1.61

Last Trade

340

1.61

(formt)

Last Trade Time

Financial Volume

$ 519,970

VWAP

1.6003

Average Volume (3m)

1,724,546

Shares Outstanding

37,811,970

Dividend Yield

PE Ratio

-0.84

Earnings Per Share (EPS)

-1.97

Revenue

Net Profit

-74.56M

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.rallybio.com.

Headquarters

Wilmington, Delaware, USA

Founded

1970

Rallybio Holdings LLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was $1.58. Over the last year, Rallybio shares have traded in a share price range of $ 1.225 to $ 9.14.

Rallybio currently has 37,811,970 shares outstanding. The market capitalization of Rallybio is $62.77 million. Rallybio has a price to earnings ratio (PE ratio) of -0.84.

FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting

- Data Support HPA-1a Negative Frequency of More than 2% in Nearly 200,000 Screened Pregnant Women - - Among HPA-1a Negative Pregnant Women, Approximately 33% are at Higher Risk for...

Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

- Rallybio to Receive Funding for FNAIT Awareness Initiative and Equity Investment from Johnson & Johnson - Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.19	-10.5555555556	1.8	1.88	1.54	291609	1.70223751	CS
4	0.01	0.625	1.6	3.46	1.54	4800378	2.84718926	CS
12	0.25	18.3823529412	1.36	3.46	1.225	1724546	2.74883767	CS
26	-1.76	-52.2255192878	3.37	4.6	1.225	887773	2.6988489	CS
52	-3.16	-66.2473794549	4.77	9.14	1.225	478348	2.97415666	CS
156	-13.31	-89.2091152815	14.92	25.78	1.225	232946	4.83814853	CS
260	-13.31	-89.2091152815	14.92	25.78	1.225	232946	4.83814853	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ISUNiSun Inc	$ 0.173 (84.04%)	19.93M
BRFHBarfresh Food Group Inc	$ 1.75 (69.90%)	44.33M
SGBXSafe and Green Holdings Corporation	$ 0.225 (56.14%)	136.91M
PCSAProcessa Pharmaceuticals Inc	$ 2.4137 (48.99%)	77.21M
BACKIMAC Holdings Inc	$ 5.065 (45.34%)	8.49M
EJHE Home Household Service Holdings Ltd	$ 0.767 (-73.64%)	12.36M
TVGNTevogen Bio Holdings Inc	$ 0.9057 (-39.62%)	328.69k
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.265 (-37.69%)	16.75M
ATNIATN International Inc	$ 19.24 (-33.01%)	440.2k
BNAIBrand Engagement Network Inc	$ 2.59 (-30.56%)	234.29k
SQQQProShares UltraPro Short QQQ	$ 12.00 (1.61%)	167.48M
SGBXSafe and Green Holdings Corporation	$ 0.225 (56.14%)	136.91M
TSLATesla Inc	$ 170.18 (4.97%)	126.42M
ACONAclarion Inc	$ 0.383149 (33.04%)	115.53M
TQQQProShares UltraPro QQQ	$ 52.85 (-1.60%)	86.41M